Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Market Intelligence Pricing Strategies United Kingdom

Exemestane Prices Tumble As UK Sees Reductions

Pricewatch UK – November 2020

  • Data

Executive Summary

Exemestane 25mg tablets saw their average UK trade price drop by a third in November, according to the latest figures from WaveData.

You may also be interested in...



Zonisamide Zooms Up In October

Zonisamide presentations saw average price increases of as much as five times in October, according to the latest UK figures from WaveData.

UK Paracetamol Prices Treble Amid Coronavirus Demand

Average UK trade prices for paracetamol more than trebled in March as the coronavirus outbreak took hold, while the antiviral valaciclovir saw an average increase of over 300%.

Indoco Builds On Recent Growth With Acquisition In US

Indoco says it has marked a major milestone with a $4m deal to take a controlling stake in US firm Florida Pharmaceutical Products, strengthening the Indian company’s position in the US market.

Table

View full table

Topics

Tags:
Market Intelligence Pricing Strategies United Kingdom
Latest Headlines

Indoco Builds On Recent Growth With Acquisition In US

Stada Gets FDA Nod For US Epoetin Alfa Supply

Dr Reddy’s CEO: We’re In ‘Great Dialogue’ With The Innovation Industry In China

AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification

See All
UsernamePublicRestriction

Register

GB150506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By